| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.RES.88.1.103 |
| P698 | PubMed publication ID | 11139481 |
| P50 | author | Jean-Daniel Chiche | Q42222159 |
| P2093 | author name string | Collen D | |
| Bloch KD | |||
| Van Pelt N | |||
| Gillijns H | |||
| Janssens S | |||
| Sinnaeve P | |||
| Varenne O | |||
| Nong Z | |||
| P433 | issue | 1 | |
| P304 | page(s) | 103-109 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Soluble guanylate cyclase alpha(1) and beta(1) gene transfer increases NO responsiveness and reduces neointima formation after balloon injury in rats via antiproliferative and antimigratory effects | |
| P478 | volume | 88 |
| Q27319501 | A peptide against soluble guanylyl cyclase α1: a new approach to treating prostate cancer |
| Q40233581 | Androgen regulation of soluble guanylyl cyclasealpha1 mediates prostate cancer cell proliferation |
| Q92460246 | Aortic pathology from protein kinase G activation is prevented by an antioxidant vitamin B12 analog |
| Q35095408 | Applied gene therapy in preclinical models of vascular injury |
| Q38636638 | Bacterial heme-based sensors of nitric oxide |
| Q33701401 | COP9 subunits 4 and 5 target soluble guanylyl cyclase α1 and p53 in prostate cancer cells |
| Q37346565 | Gender-specific modulation of the response to arterial injury by soluble guanylate cyclase α1. |
| Q36707618 | Gene therapy for restenosis: biological solution to a biological problem |
| Q35020341 | Molecular approaches for the treatment of atherosclerosis |
| Q24656131 | NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential |
| Q24645400 | Nitric oxide and peroxynitrite in health and disease |
| Q49789143 | Redox control of vascular smooth muscle cell function and plasticity. |
| Q37692538 | Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis |
| Q45037115 | Regulation of cGMP-dependent protein kinase expression by soluble guanylyl cyclase in vascular smooth muscle cells |
| Q35141387 | Regulation of neuronal proliferation and differentiation by nitric oxide |
| Q38367012 | Role of sGC-dependent NO signalling and myocardial infarction risk |
| Q41865010 | Role of smooth muscle cGMP/cGKI signaling in murine vascular restenosis |
| Q41869044 | Soluble guanylyl cyclase-activated cyclic GMP-dependent protein kinase inhibits arterial smooth muscle cell migration independent of VASP-serine 239 phosphorylation |
| Q38130465 | The chemistry and biology of soluble guanylate cyclase stimulators and activators |
| Q43073192 | Vascular biology and pathobiology of the liver: Report of a single-topic symposium |
| Q35027751 | Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis |
| Q35087054 | sGC{alpha}1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling |
Search more.